Related Experiment Video
Updated: Jun 11, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Best way to revascularize patients with main stem and three-vessel lesions. Patients should be operated!
H Reichenspurner1, L Conradi, J Cremer
1Department of Cardiovascular Surgery, University Heart Center Hamburg, University Medical Center Hamburg Eppendorf, Martinistr. 52, 20246, Hamburg, Germany. hcr@uke.de
Insights
Coronary artery bypass grafting (CABG) is superior to percutaneous coronary intervention (PCI) for complex coronary artery disease (CAD). CABG remains the standard of care for patients with three-vessel or left main CAD.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Current clinical practice often favors percutaneous coronary intervention (PCI) for complex coronary artery disease (CAD), diverging from established treatment guidelines.
- Numerous clinical trials, including observational and randomized studies, consistently demonstrate the superiority of coronary artery bypass grafting (CABG) over PCI.
- This superiority extends to critical outcomes such as cardiac death and myocardial infarction, as highlighted by landmark trials like SYNTAX.
Purpose of the Study:
- To evaluate the comparative effectiveness of CABG versus PCI in treating complex coronary artery disease.
- To reinforce the established guidelines and clinical evidence supporting CABG as the preferred treatment for specific CAD patient groups.
Main Methods:
- Analysis of evidence from observational and randomized clinical trials.
- Integration of current treatment guidelines and interdisciplinary expert opinions.
- Review of landmark studies such as the SYNTAX trial.
Main Results:
- CABG demonstrates superiority over PCI in treating multivessel and left main coronary artery disease in symptomatic patients.
- The SYNTAX trial confirmed the advantage of CABG for hard endpoints like cardiac death and myocardial infarction.
- Appropriateness criteria developed from guidelines and trial data echo the SYNTAX findings.
Conclusions:
- Coronary artery bypass grafting (CABG) remains the established standard of care for patients with three-vessel or left main coronary artery disease.
- Despite evolving practices, robust evidence supports CABG over PCI for complex CAD, particularly concerning hard clinical outcomes.
- Clinical decision-making for complex CAD should align with evidence-based guidelines emphasizing CABG's role.
Abstract:
Despite established guidelines for the treatment of coronary artery disease (CAD) by either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI), everyday clinical practice has proven to differ substantially with even the most complex coronary lesions being targeted by PCI today. However, an abundancy of clinical trials, both observational and randomized has proven the superiority of coronary surgery over PCI in almost every type of multivessel or left main CAD in symptomatic patients. This holds true also for 'hard' endpoints like cardiac death or myocardial infarction as recently demonstrated by the landmark SYNTAX trial. These results have lead to the wording of appropriateness criteria, which integrate current guidelines, evidence from clinical trials and interdisciplinary expert opinion and which express essentially the same message as the SYNTAX trial: "CABG remains the standard of care for patients with three-vessel or left main coronary artery disease"
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Aneurysm III: Interprofessional Care
Mitral Stenosis III: Medical Management